Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers (Q38551776)

From Wikidata

Jump to navigation Jump to search

scientific article published on July 2015

Language	Label	Description	Also known as
English	Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers	scientific article published on July 2015

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

1 reference

Europe PubMed Central

Strategies for early detection of cardiotoxicities from anticancer therapy in adults: evolving imaging techniques and emerging serum biomarkers (English)

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

0 references

3

object named as

Clyde Yancy

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

author name string

Nausheen Akhter

1

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Gillian Murtagh

2

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

language of work or name

0 references

publication date

1 July 2015

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Future Oncology

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

11

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

14

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

2093-2103

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Anthracycline-induced cardiomyopathy: clinical relevance and response to pharmacologic therapy.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Prognostic value of troponin I in cardiac risk stratification of cancer patients undergoing high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Myocardial injury revealed by plasma troponin I in breast cancer treated with high-dose chemotherapy

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Prevention of high-dose chemotherapy-induced cardiotoxicity in high-risk patients by angiotensin-converting enzyme inhibition

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Trastuzumab-Induced Cardiotoxicity: Clinical and Prognostic Implications of Troponin I Evaluation

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Serum troponin T levels and echocardiographic evaluation in children treated with doxorubicin

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Radiation-induced heart disease: pathologic abnormalities and putative mechanisms

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Cardiac blood biomarkers in patients receiving thoracic (chemo)radiation

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

N-terminal pro-B-type natriuretic peptide plasma levels as a potential biomarker for cardiac damage after radiotherapy in patients with left-sided breast cancer.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Early diagnosis of myocardial infarction with sensitive cardiac troponin assays

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Early detection and prediction of cardiotoxicity in chemotherapy-treated patients

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Assessment of echocardiography and biomarkers for the extended prediction of cardiotoxicity in patients treated with anthracyclines, taxanes, and trastuzumab

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Elevated B-type natriuretic peptide levels after anthracycline administration

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Cardiotoxicity after anthracycline chemotherapy in breast carcinoma: effects on left ventricular ejection fraction, troponin I and brain natriuretic peptide

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Natriuretic peptides during the development of doxorubicin-induced left ventricular diastolic dysfunction

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

BNP cannot replace gated equilibrium radionuclide ventriculography in monitoring of anthracycline-induced cardiotoxity

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Prognostic value and echocardiographic determinants of plasma myeloperoxidase levels in chronic heart failure

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Myeloperoxidase and C-reactive protein augment the specificity of B-type natriuretic peptide in community screening for systolic heart failure.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Early increases in multiple biomarkers predict subsequent cardiotoxicity in patients with breast cancer treated with doxorubicin, taxanes, and trastuzumab

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Comparison of interstudy reproducibility of cardiovascular magnetic resonance with two-dimensional echocardiography in normal subjects and in patients with heart failure or left ventricular hypertrophy.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Accuracy of accelerated cine MR imaging at 3 Tesla in longitudinal follow-up of cardiac function.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Normalized Left Ventricular Systolic and Diastolic Function by Steady State Free Precession Cardiovascular Magnetic Resonance

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Reduction in sample size for studies of remodeling in heart failure by the use of cardiovascular magnetic resonance

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Comparison of left ventricular ejection fraction and volumes in heart failure by echocardiography, radionuclide ventriculography and cardiovascular magnetic resonance; are they interchangeable?

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Screening adult survivors of childhood cancer for cardiomyopathy: comparison of echocardiography and cardiac magnetic resonance imaging

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Left ventricular mass in patients with a cardiomyopathy after treatment with anthracyclines

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Independent and incremental value of deformation indices for prediction of trastuzumab-induced cardiotoxicity

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Low to moderate dose anthracycline-based chemotherapy is associated with early noninvasive imaging evidence of subclinical cardiovascular disease

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Nephrogenic systemic fibrosis: incidence, associations, and effect of risk factor assessment--report of 33 cases

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Degree of diffuse fibrosis measured by MRI correlates with LV remodelling in childhood cancer survivors after anthracycline chemotherapy.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Diffuse myocardial fibrosis by T1-mapping in children with subclinical anthracycline cardiotoxicity: relationship to exercise capacity, cumulative dose and remodeling.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Myocardial extracellular volume by cardiac magnetic resonance imaging in patients treated with anthracycline-based chemotherapy

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Longitudinal assessment of concurrent changes in left ventricular ejection fraction and left ventricular myocardial tissue characteristics after administration of cardiotoxic chemotherapies using T1-weighted and T2-weighted cardiovascular magnetic r

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Cardiac MRI in the assessment of cardiac injury and toxicity from cancer chemotherapy: a systematic review.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Prospective longitudinal assessment of late anthracycline cardiotoxicity after childhood cancer: the role of diastolic function

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Altered left ventricular longitudinal diastolic function correlates with reduced systolic function immediately after anthracycline chemotherapy.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Tissue Doppler imaging and conventional echocardiography after anthracycline treatment in adults: early and late alterations of left ventricular function during a prospective study.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Use of echocardiography to evaluate the cardiac effects of therapies used in cancer treatment: what do we know?

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Echocardiographic quantification of myocardial function using tissue deformation imaging, a guide to image acquisition and analysis using tissue Doppler and speckle tracking

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Assessment of myocardial mechanics using speckle tracking echocardiography: fundamentals and clinical applications.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Current and evolving echocardiographic techniques for the quantitative evaluation of cardiac mechanics: ASE/EAE consensus statement on methodology and indications endorsed by the Japanese Society of Echocardiography

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Definitions for a common standard for 2D speckle tracking echocardiography: consensus document of the EACVI/ASE/Industry Task Force to standardize deformation imaging.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Use of myocardial strain imaging by echocardiography for the early detection of cardiotoxicity in patients during and after cancer chemotherapy: a systematic review.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Myocardial 2D strain echocardiography and cardiac biomarkers in children during and shortly after anthracycline therapy for acute lymphoblastic leukaemia (ALL): a prospective study.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Early detection of anthracycline-mediated cardiotoxicity: the value of considering both global longitudinal left ventricular strain and twist

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Use of myocardial deformation imaging to detect preclinical myocardial dysfunction before conventional measures in patients undergoing breast cancer treatment with trastuzumab.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Changes in left ventricular longitudinal strain with anthracycline chemotherapy in adolescents precede subsequent decreased left ventricular ejection fraction.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Subclinical anthracycline- and trastuzumab-induced cardiotoxicity in the long-term follow-up of asymptomatic breast cancer survivors: a speckle tracking echocardiographic study.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Use of speckle strain to assess left ventricular responses to cardiotoxic chemotherapy and cardioprotection.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Time Trends of Left Ventricular Ejection Fraction and Myocardial Deformation Indices in a Cohort of Women with Breast Cancer Treated with Anthracyclines, Taxanes, and Trastuzumab.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Strain rate imaging detects early cardiac effects of pegylated liposomal Doxorubicin as adjuvant therapy in elderly patients with breast cancer.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Early detection of epirubicin-induced cardiotoxicity in patients with breast cancer.

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

The prevention, detection and management of cancer treatment-induced cardiotoxicity: a meta-review

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Pro1170 Ala polymorphism in HER2-neu is associated with risk of trastuzumab cardiotoxicity

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Expert Consensus for Multimodality Imaging Evaluation of Adult Patients during and after Cancer Therapy: A Report from the American Society of Echocardiography and the European Association of Cardiovascular Imaging

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Myocardial Dysfunction Late After Low-Dose Anthracycline Treatment in Asymptomatic Pediatric Patients

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Cardiovascular magnetic resonance imaging in early anthracycline cardiotoxicity

1 reference

https://api.crossref.org/works/10.2217%2FFON.15.139

21 January 2018

Identifiers

10.2217/FON.15.139

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

4 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38551776&oldid=2197864449"